Pfizer Newsroom

Berenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE)

TipRanksAug 23 06:27 ET

Pfizer Analyst Ratings

BenzingaAug 19 12:29 ET

Citigroup Adjusts Price Target on Pfizer to $30 From $28, Maintains Neutral Rating

MT NewswiresAug 14 06:08 ET

Pfizer Analyst Ratings

BenzingaAug 8 13:40 ET

Daiwa Securities Upgrades Pfizer to Outperform From Neutral, Adjusts Price Target to $34 From $28

MT NewswiresAug 7 06:25 ET

Truist Financial Maintains Pfizer(PFE.US) With Buy Rating

Moomoo NewsAug 6 07:33 ET

Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer

BenzingaAug 2 14:23 ET

Argus Research Maintains Pfizer(PFE.US) With Hold Rating

Moomoo NewsAug 1 10:32 ET

Pfizer Price Target Maintained With a $45.00/Share by Cantor Fitzgerald

Dow JonesJul 31 11:50 ET

Pfizer Price Target Raised to $31.00/Share From $30.00 by UBS

Dow JonesJul 31 11:42 ET

Pfizer Analyst Ratings

BenzingaJul 31 11:32 ET

DZ BANK AG Maintains Pfizer(PFE.US) With Buy Rating

Moomoo NewsJul 31 11:31 ET

BofA Securities Maintains Pfizer(PFE.US) With Hold Rating

Moomoo NewsJul 31 10:33 ET

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $32 to $45

Moomoo NewsJul 31 09:18 ET

Cantor Fitzgerald Sticks to Its Buy Rating for Pfizer (PFE)

TipRanksJul 31 08:08 ET

Truist Financial Keeps Their Buy Rating on Pfizer (PFE)

TipRanksJul 31 08:03 ET

Morgan Stanley Raises Price Target on Pfizer to $31 From $29, Keeps Equalweight Rating

MT NewswiresJul 31 06:29 ET

Pfizer Hold Rating Maintained Amid Growth Challenges and Valuation Concerns

TipRanksJul 31 06:23 ET

Barclays Remains a Hold on Pfizer (PFE)

TipRanksJul 31 04:05 ET

Jefferies Adjusts Price Target on Pfizer to $35 From $34, Keeps Buy Rating

MT NewswiresJul 30 12:23 ET